A global manufacturer will close its Charlotte facility and fold those operations into another North Carolina location.

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...

Nemluvio is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31, which drives itch and is involved in inflammation and skin barrier ...

There was guarded optimism among military experts in India as Prime Minister Narendra Modi and U.S. President Donald Trump ...

Debbie Monfries has been fighting to get the giant telecoms boxes outside her restaurant removed since 2012 and said she ...

The flagship energy event, now touted as the second biggest energy event in the world, commenced on February 11 and concluded ...